Glenmark Pharma inks settlement pact with Pfizer for cancer drug

The Mumbai-based drug maker and its US-based unit have inked a settlement pact with drug major Pfizer Inc for Axitinib Tablets (1 mg and 5 mg). Glenmark's product is the generic version of Pfizer's Inlyta tablets, used to treat kidney cancer.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/htFTVrE
via IFTTT